Works matching IS 16187598 AND DT 2024 AND VI 25 AND IP 6
Results: 12
Country-level effects of diagnosis-related groups: evidence from Germany's comprehensive reform of hospital payments.
- Published in:
- European Journal of Health Economics, 2024, v. 25, n. 6, p. 1013, doi. 10.1007/s10198-023-01645-z
- By:
- Publication type:
- Article
Beyond 10-year lead-times in EQ-5D-5L: leveraging alternative lead-times in willingness-to-accept questions to capture preferences for worse-than-dead states and their implication.
- Published in:
- European Journal of Health Economics, 2024, v. 25, n. 6, p. 1041, doi. 10.1007/s10198-023-01642-2
- By:
- Publication type:
- Article
The elicitation of patient and physician preferences for calculating consumer-based composite measures on hospital report cards: results of two discrete choice experiments.
- Published in:
- European Journal of Health Economics, 2024, v. 25, n. 6, p. 1071, doi. 10.1007/s10198-023-01650-2
- By:
- Publication type:
- Article
Bayesian cost-effectiveness analysis of Whole genome sequencing versus Whole exome sequencing in a pediatric population with suspected genetic disorders.
- Published in:
- European Journal of Health Economics, 2024, v. 25, n. 6, p. 999, doi. 10.1007/s10198-023-01644-0
- By:
- Publication type:
- Article
Projected costs of informal care for older people in England.
- Published in:
- European Journal of Health Economics, 2024, v. 25, n. 6, p. 1057, doi. 10.1007/s10198-023-01643-1
- By:
- Publication type:
- Article
Patient-reported experience is associated with higher future revenue and lower costs of hospitals.
- Published in:
- European Journal of Health Economics, 2024, v. 25, n. 6, p. 1031, doi. 10.1007/s10198-023-01646-y
- By:
- Publication type:
- Article
Healthcare information management and operational cost performance: empirical evidence.
- Published in:
- European Journal of Health Economics, 2024, v. 25, n. 6, p. 963, doi. 10.1007/s10198-023-01641-3
- By:
- Publication type:
- Article
Special FDA designations for drug development: orphan, fast track, accelerated approval, priority review, and breakthrough therapy.
- Published in:
- European Journal of Health Economics, 2024, v. 25, n. 6, p. 979, doi. 10.1007/s10198-023-01639-x
- By:
- Publication type:
- Article
New evidence on supplier-induced demand in China's public tertiary hospitals: is the cost of hospitalization higher in the off-season?
- Published in:
- European Journal of Health Economics, 2024, v. 25, n. 6, p. 951, doi. 10.1007/s10198-023-01638-y
- By:
- Publication type:
- Article
How can health technology assessment be improved to optimise access to medicines? Results from a Delphi study in Europe: Better access to medicines through HTA.
- Published in:
- European Journal of Health Economics, 2024, v. 25, n. 6, p. 935, doi. 10.1007/s10198-023-01637-z
- By:
- Publication type:
- Article
Valuation of EQ-5D-5L health states from cancer patients' perspective: a feasibility study.
- Published in:
- European Journal of Health Economics, 2024, v. 25, n. 6, p. 915, doi. 10.1007/s10198-023-01635-1
- By:
- Publication type:
- Article
The economic burden of mental disorders: results from the Netherlands mental health survey and incidence study-2.
- Published in:
- European Journal of Health Economics, 2024, v. 25, n. 6, p. 925, doi. 10.1007/s10198-023-01634-2
- By:
- Publication type:
- Article